Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Biocompatibility: Biological Response Biocompatibility Tests Sterilization Issues

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 41

Biocompatibility

Biological response
Biocompatibility tests
Sterilization Issues
Biocompatibility

• Arises from differences between living and non-


living materials
• Bioimplants trigger inflammation or foreign body
response
• New biomaterials must be tested prior to
implantation according to FDA regulation
• WWII: Validated biocompatibility of several
materials including PMMA
Biomaterial-Tissue Interactions
Definitions
• Neutrophil- common leucocyte of the blood- short-lived phagocytic cell
• Lymphocyte- small cell in blood- recirculates through tissues and back through lymph
--polices body for non-self material-- recognizes antigens through surface receptors
• Antigen- produces antibody- stimulate adaptive immune response
• Antibody- Serum globulins with wide range of specificity for different antigens-- bind
to surface
• Monocyte- largest nucleated cell of blood-develops into macrophage when it migrates
to tissues
• Macrophage- phagocyte--scavenger cell-- of tissues
• Lysozyme- enzyme secreted by macrophages- attack cell wall of bacteria “natural
antibiotic”
• Mast Cell- large tissue cell which releases inflammatory mediators-- increases
vascular permeability-- allows complement to enter tissues from blood
• Complement- a series of enzymes in blood- when activated produce inflammatory
effects
Response to implantation

• Inflammation
• Acute inflammation
• Chronic inflammation
• Granulation tissue
• Foreign Body Reaction
• Fibrosis and Encapsulation
Inflammation

• Inflammation is the reaction of vascularized


living tissue to injury.
• The inflammation process includes a sequence of
events that can heal the implant site.
• This is done through the generation of new tissue
via native parenchymal cells or the formation of
fibroblastic scar tissue.
Inflammation process

• Enhanced permeability of
vasculature
• Fluid, proteins, blood cells escape
vascular system into the injured
tissue
• Blood clotting --thrombosis is
possible
• Cell response--neutrophils (24-48
hrs)
• Monocytes macrophages (months)

Marieb, EN and Mallatt, J. 1997. Human


Anatomy
Acute Inflammation
• Short term (minutesdays)
• Exudation of fluid, plasma, proteins, and
leukocytes (neutrophils).
• Phagocytosis and enzymatic release occurs.
• Activation of neutrophils and macrophages--digest foreign material--
involves recognition, attachment, engulfment, and degradation.
• Recognition and attachment is enhanced when serum factors,
Opsonins present—immunoglobin G (IgG), complement activated
fragment C3b--can adsorb to biomaterials.
• Neutrophils and macrophages have receptors for these proteins.
• Due to size disparity, however, frustrated phagocytosis may occur—
this results in extracellular release of leukocyte products in a cellular
attempt to degrade the biomaterial.
Chronic Inflammation

• Long term (≥≥ days).


• Characterized by the presence of
macrophages, monocytes, and
mononuclear cells including lymphocytes
and plasma cells.
• Accompanied by the proliferation of
blood vessels and connective tissue.
• Lymphocytes and plasma cells are
involved in the immune reactions-
mediate antibody production. www.lumen.com
• Macrophages process and deliver
antigen to immunocompetent cells—
mediate immune reactions.
Cellular pathways

• Macrophages along with monocytes belong to the mononuclear


phagocytic system (MPS) or the reticuloendothelial system (RES).
• These systems include the cells in the bone marrow, peripheral
blood, and specialized tissues (liver, lung, connective, lymphoid).
• The macrophage is a key cell in the inflammation process as it can
produce a large number of biologically active products including
proteases, complement components, coagulation factors, growth
factors and cytokines (proteins that regulate immune response).
 Growth factors include (FBF)-fibroblast growth factor, (TNF) tumor
necrosis factor, (IL-1) interleukin-1... These are important for the
growth of fibroblasts, blood vessels, epithelial cells... and play a key
role in tissue remodeling and wound healing.
Biological Response

Corrosion, Wear, Fracture

Osteolysis
DEBRIS

CYTOKINES FOREIGN
BODY
RESPONSE
Wear-Mediated Osteolysis

Wear particles from


the replacement head
and liner cause
inflammation that can
lead to pain, bone
loss, and ultimately
revision surgery
wear
particles

bone loss

Archibeck, MJ; Jacobs, JJ; Roebuck, KA; Glant, TT. Journal of Bone & Joint Surgery, 2000
Granulation tissue
• Within 24 hrs of implantation, healing initiated by
the action of monocytes and macrophages.
• Fibroblasts and vascular endothelial cells reproduce
and form granulation tissue (pink, granular
appearance)
• Neovascularization involves the generation,
maturation, and organization of endothelial cells into
capillary tubes.
• Fibroblasts are active in the synthesis of
proteoglycans and collagen (type III predominantly).
• Granulation tissue may be observed within 3-5 days
of implantation of a biomaterial—it is often
accompanied by wound contraction.
Foreign Body Reaction

• Indicated by the presence of multinucleated


foreign body giant cells and the components
of granulation tissue (macrophages,
fibroblasts, and capillaries)
• Observed in silicone breast implants
• Surface of the biomaterial will often
determine the composition of the foreign
body response
Surface structure important for
biocompatibility
• High surface to volume ratio of
fabrics and porous structures can
result in higher ratios of
macrophages than a smooth
component made of the identical
material but can also encourage
tissue ingrowth --this is observed in
vascular grafts.
Fibrosis and Encapsulation
• The final stage of the foreign body response and healing
process is the development of a fibrous encapsulation
(porous structures may be excluded from this stage due to
tissue ingrowth).
• Repair involves two separate processes: replacement of
tissue by parenchymal cells of the same type or replacement
by connective tissue that constitute the fibrous capsule.
• These processes are controlled by the growth capacity of
the cells in the tissue receiving the implant, the persistence
of the tissue framework and degree of injury.
Response to the inflammatory
challenge
• Decreased tissue mass and formation of new
tissue through granulation
• Collagen and other molecules are synthesized
• Formation of scar tissue
• Remodeling process differs for various tissues
Implant Factors

• Bulk properties: chemical composition, structure,


purity and presence of leachables.
• Surface properties: smoothness, COF, geometry,
hyrophilicity, surface charge
• Mechanical properties: match properties of
component being replaced, such as elastic
modulus. Stability and fixation.
• Long-term structural integrity: design for fatigue
and fracture loading, wear, creep, and stress
corrosion cracking
Bioactivity spectra for bioceramics
Reactivity of Ceramics

• Bioinert- Pyrolytic carbon (heart valves),


Alumina/Zirconia (orthopedic femoral heads)
• Biodegradable- Calcium phosphate (artificial
bone), tricalcium phosphate (peridontal defect
repair)
• Bioactive-glass ceramics (coatings pf
orthopedic devices, bone plates).
Host can affect the implant

• Physically
• Abrasive, adhesive, delamination wear
• Fatigue and Fracture
• Stress Corrosion cracking
• General corrosion
• Biologically
• Absorption of substances from the tissues
• Enzymatic degradation
• Calcification
Implant reactions in the body
Host Factors

• Age and health status


• Immunological/metabolic status
• Choice of surgeon: minimize tissue
damage and contamination, proper
implantation
Biocompatibility testing

• Cell toxicity
• Thromobogenecity
• Inflammatory response
• Animal tests
• Clinical trials
• FDA regulations
• ASTM/ISO standards
Device sterility

• Minimizes bacterial contamination


• Reduces likelihood for infection
• Can alter the material surface and bulk
structure
Design Issues

• Shelf Aging-- Post Sterilization --Manufacturing


issues-- what is the best sterilization method?
What is shelf life for the device?
Pre-Surgical Implant Life
medical grade UHMWPE resin

compression molded extruded direct compression molded

“blocks” of UHMWPE rod of UHMWPE


machined

component

sterilization

shelf aging

implanted
STERILIZATION

• One of the greatest challenges for devices is


ensuring sterility
• Many in-vivo degradation schemes have been
linked to loss of mechanical properties due to
post-sterilization aging
Sterilization

Sterility Definition: the state in which the


probability of any one bacterial endospore
-6
surviving is 10 or lower

Common Method: 25 kGy of 60Co gamma


radiation in air
STERILIZATION SCHEMES

• Eto Gas
• Steam
• Autoclaving
• E-beam radiation
• Gamma Radiation*
Gamma Radiation

• Advantages:
• deeply penetrating
• no residuals
• no post-sterilization treatment
• crosslinking- good for wear resistance

• Disadvantages:
• chain cleavage, loss of molecular weight and higher crystallinity
• embrittlement
Oxygen aids in high reactivity towards free radical
generation in radiation sterilization schemes

• R -- --> R.} initiation


• R. --O2--> RO2. } propagation
• RO2. --RH-> RO2H + R. }
• RO2H --RH-> RO. + . OH } chain branching
• RO. --RH-> ROH + R. }
• .OH --RH-> H O + R.
2

• RO2H, RO2., R. -----> scission and crosslinking


• 2RO2. ----> RO2R + O2} termination
Structural changes due to gamma
sterilization and aging in UHMWPE

• Increased crystallinity and density


• Increased oxidation levels
• Loss of fatigue and fracture properties
DSC: Crystallinity

60

50
Sterile Material has
40 greater crystallinity after
five years
30
% Crystallinity Implies chain scission

20 in sterilized material

10

0
Nonsterile Sterile
Density evolution

0.98
Unsterilized n=18
0.97
Density (g/cc)

Sterilized in N 2
0.96 Sterilized in Air

0.95

0.94

0.93
0 1 2 3 4
Aging Time (Weeks)
TEM:microstructure evolution
(aging)

unaged aged
Oxidation Model
Sterilization affects fatigue resistance

GUR4150HP unaged
-3
10
d a /d N (m m /cy cle)

-4
10

-5
10
G415Gi
G415NS
G415GA
G415P
G415Eto
-6
10
1 2 3 4

²K (MPa¦m)
Current Trends

• Sterilization with EtO or Gas Plasma


• Controlled crosslinking with ionizing schemes
(Gamma inert, melt irradiated, E-beam--
controlled crosslinking)
Questions?

You might also like